• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共价抑制剂通过变构作用阻断Rho家族蛋白的激活并抑制癌细胞侵袭。

Covalent Inhibitors Allosterically Block the Activation of Rho Family Proteins and Suppress Cancer Cell Invasion.

作者信息

Sun Zhongya, Zhang Hao, Zhang Yuanyuan, Liao Liping, Zhou Wen, Zhang Fengcai, Lian Fulin, Huang Jing, Xu Pan, Zhang Rukang, Lu Wenchao, Zhu Mingrui, Tao Hongru, Yang Feng, Ding Hong, Chen Shijie, Yue Liyan, Zhou Bing, Zhang Naixia, Tan Minjia, Jiang Hualiang, Chen Kaixian, Liu Bo, Liu Chuanpeng, Dang Yongjun, Luo Cheng

机构信息

School of Life Science and Technology Harbin Institute of Technology Harbin 150001 China.

Drug Discovery and Design Center State Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China.

出版信息

Adv Sci (Weinh). 2020 May 13;7(14):2000098. doi: 10.1002/advs.202000098. eCollection 2020 Jul.

DOI:10.1002/advs.202000098
PMID:32714746
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7375240/
Abstract

The Rho family GTPases are crucial drivers of tumor growth and metastasis. However, it is difficult to develop GTPases inhibitors due to a lack of well-characterized binding pockets for compounds. Here, through molecular dynamics simulation of the RhoA protein, a groove around cysteine 107 (Cys107) that is relatively well-conserved within the Rho family is discovered. Using a combined strategy, the novel inhibitor DC-Rhoin is discovered, which disrupts interaction of Rho proteins with guanine nucleotide exchange factors (GEFs) and guanine nucleotide dissociation inhibitors (GDIs). Crystallographic studies reveal that the covalent binding of DC-Rhoin to the Cys107 residue stabilizes and captures a novel allosteric pocket. Moreover, the derivative compound DC-Rhoin04 inhibits the migration and invasion of cancer cells, through targeting this allosteric pocket of RhoA. The study reveals a novel allosteric regulatory site within the Rho family, which can be exploited for anti-metastasis drug development, and also provides a novel strategy for inhibitor discovery toward "undruggable" protein targets.

摘要

Rho家族GTP酶是肿瘤生长和转移的关键驱动因素。然而,由于缺乏特征明确的化合物结合口袋,开发GTP酶抑制剂具有一定难度。在此,通过对RhoA蛋白进行分子动力学模拟,发现了一个围绕半胱氨酸107(Cys107)的凹槽,该凹槽在Rho家族中相对保守。采用联合策略,发现了新型抑制剂DC-Rhoin,它可破坏Rho蛋白与鸟嘌呤核苷酸交换因子(GEFs)和鸟嘌呤核苷酸解离抑制剂(GDIs)的相互作用。晶体学研究表明,DC-Rhoin与Cys107残基的共价结合稳定并捕获了一个新的变构口袋。此外,衍生物化合物DC-Rhoin04通过靶向RhoA的这个变构口袋,抑制癌细胞的迁移和侵袭。该研究揭示了Rho家族内一个新的变构调节位点,可用于抗转移药物开发,也为针对“不可成药”蛋白靶点的抑制剂发现提供了新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3f/7375240/e059ef5d78fb/ADVS-7-2000098-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3f/7375240/c990241851ae/ADVS-7-2000098-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3f/7375240/207444588ad2/ADVS-7-2000098-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3f/7375240/60c3e9fb5380/ADVS-7-2000098-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3f/7375240/e059ef5d78fb/ADVS-7-2000098-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3f/7375240/c990241851ae/ADVS-7-2000098-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3f/7375240/207444588ad2/ADVS-7-2000098-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3f/7375240/60c3e9fb5380/ADVS-7-2000098-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f3f/7375240/e059ef5d78fb/ADVS-7-2000098-g004.jpg

相似文献

1
Covalent Inhibitors Allosterically Block the Activation of Rho Family Proteins and Suppress Cancer Cell Invasion.共价抑制剂通过变构作用阻断Rho家族蛋白的激活并抑制癌细胞侵袭。
Adv Sci (Weinh). 2020 May 13;7(14):2000098. doi: 10.1002/advs.202000098. eCollection 2020 Jul.
2
The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.鸟嘌呤核苷酸交换因子 Tiam1:细胞信号转导中的双面分子。
Cell Signal. 2014 Mar;26(3):483-91. doi: 10.1016/j.cellsig.2013.11.034. Epub 2013 Dec 2.
3
Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket.通过保守的隐匿口袋靶向 Ras-、Rho- 和 Rab 家族 GTPases。
Cell. 2024 Oct 31;187(22):6379-6392.e17. doi: 10.1016/j.cell.2024.08.017. Epub 2024 Sep 9.
4
Covalent Fragment Inhibits RhoA Activation by Guanine Exchange Factors.共价片段通过鸟嘌呤交换因子抑制 RhoA 的激活。
ACS Chem Neurosci. 2023 Jul 19;14(14):2509-2516. doi: 10.1021/acschemneuro.3c00154. Epub 2023 Jun 29.
5
Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors.靶向 G 蛋白偶联 Rho 鸟苷酸交换因子的小分子抑制剂。
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3155-60. doi: 10.1073/pnas.1212324110. Epub 2013 Feb 4.
6
Residues of the Rho family GTPases Rho and Cdc42 that specify sensitivity to Dbl-like guanine nucleotide exchange factors.Rho家族GTP酶Rho和Cdc42的残基,其决定了对Dbl样鸟嘌呤核苷酸交换因子的敏感性。
J Biol Chem. 1997 Feb 21;272(8):4671-9. doi: 10.1074/jbc.272.8.4671.
7
Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.Vav1和Vav2鸟嘌呤核苷酸交换因子对Rho GTP酶的识别与激活。
Biochemistry. 2005 May 3;44(17):6573-85. doi: 10.1021/bi047443q.
8
Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation.Rho GDP解离抑制剂对Rho家族GTP酶的抑制作用会破坏心脏形态发生并抑制心肌细胞增殖。
Development. 2002 Apr;129(7):1705-14. doi: 10.1242/dev.129.7.1705.
9
Mutationally activated Rho GTPases in cancer.癌症中发生突变激活的Rho GTP酶
Small GTPases. 2013 Jul-Sep;4(3):159-63. doi: 10.4161/sgtp.26530. Epub 2013 Oct 2.
10
Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant.由显性负性三联体突变体揭示的鸟嘌呤核苷酸交换和Rac介导信号传导的机制
J Biol Chem. 2004 Jan 30;279(5):3777-86. doi: 10.1074/jbc.M308282200. Epub 2003 Nov 3.

引用本文的文献

1
Mechanism of SC targeting RhoA regulation and its potential value in gastric cancer therapy.SC靶向RhoA调控的机制及其在胃癌治疗中的潜在价值。
Biochem Biophys Rep. 2025 Jul 24;43:102158. doi: 10.1016/j.bbrep.2025.102158. eCollection 2025 Sep.
2
Structural Dynamics of Rho GTPases.Rho 小 G 蛋白的结构动力学
J Mol Biol. 2025 Feb 1;437(3):168919. doi: 10.1016/j.jmb.2024.168919. Epub 2024 Dec 19.
3
Synthesis and in vitro evaluation of benzo[b]thiophene-3-carboxylic acid 1,1-dioxide derivatives as anticancer agents targeting the RhoA/ROCK pathway.

本文引用的文献

1
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.临床 KRAS(G12C) 抑制剂 AMG 510 可引发抗肿瘤免疫。
Nature. 2019 Nov;575(7781):217-223. doi: 10.1038/s41586-019-1694-1. Epub 2019 Oct 30.
2
KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition.KRAS G12C NSCLC 模型对 KRAS 的直接靶向与 PI3K 抑制联合治疗敏感。
Clin Cancer Res. 2019 Jan 15;25(2):796-807. doi: 10.1158/1078-0432.CCR-18-0368. Epub 2018 Oct 16.
3
Paving the Rho in cancer metastasis: Rho GTPases and beyond.
苯并[b]噻吩-3-羧酸 1,1-二氧化物衍生物的合成及其作为靶向 RhoA/ROCK 通路的抗癌剂的体外评价。
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2390911. doi: 10.1080/14756366.2024.2390911. Epub 2024 Sep 11.
4
Dual-site molecular glues for enhancing protein-protein interactions of the CDK12-DDB1 complex.用于增强CDK12-DDB1复合物蛋白质-蛋白质相互作用的双位点分子胶。
Nat Commun. 2024 Aug 1;15(1):6477. doi: 10.1038/s41467-024-50642-0.
5
Assessing the mechanism of fast-cycling cancer-associated mutations of Rac1 small Rho GTPase.评估 Rac1 小分子 Rho GTPase 快速循环癌相关突变的机制。
Protein Sci. 2024 Apr;33(4):e4939. doi: 10.1002/pro.4939.
6
Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS.靶向小分子 GTP 酶:KRAS 开创的针对先前无法控制的靶点的新兴方法。
Signal Transduct Target Ther. 2023 May 23;8(1):212. doi: 10.1038/s41392-023-01441-4.
7
RHO GTPase family in hepatocellular carcinoma.肝细胞癌中的RHO GTP酶家族
Exp Hematol Oncol. 2022 Nov 8;11(1):91. doi: 10.1186/s40164-022-00344-4.
8
Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease.使用从头设计的抑制剂在视网膜疾病模型中对 GEF-H1 进行治疗验证。
Cells. 2022 May 24;11(11):1733. doi: 10.3390/cells11111733.
9
Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3.发现一种针对TEAD3棕榈酰化口袋的亚型选择性共价抑制剂。
Acta Pharm Sin B. 2021 Oct;11(10):3206-3219. doi: 10.1016/j.apsb.2021.04.015. Epub 2021 May 1.
10
Inhibition of Autophagy by a Small Molecule through Covalent Modification of the LC3 Protein.小分子通过共价修饰 LC3 蛋白抑制自噬。
Angew Chem Int Ed Engl. 2021 Dec 6;60(50):26105-26114. doi: 10.1002/anie.202109464. Epub 2021 Nov 5.
在癌症转移中铺就 Rho 之路:Rho GTPases 及其以外的途径。
Pharmacol Ther. 2018 Mar;183:1-21. doi: 10.1016/j.pharmthera.2017.09.002. Epub 2017 Sep 11.
4
Covalent Guanosine Mimetic Inhibitors of G12C KRAS.G12C型KRAS的共价鸟苷类似物抑制剂
ACS Med Chem Lett. 2016 Nov 30;8(1):61-66. doi: 10.1021/acsmedchemlett.6b00373. eCollection 2017 Jan 12.
5
Rho GTPases: Regulation and roles in cancer cell biology.Rho 鸟苷三磷酸酶:在癌细胞生物学中的调控与作用
Small GTPases. 2016 Oct;7(4):207-221. doi: 10.1080/21541248.2016.1232583. Epub 2016 Sep 14.
6
Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors.Rho 小 G 蛋白、其翻译后修饰、疾病相关突变及药理抑制剂。
Small GTPases. 2018 May 4;9(3):203-215. doi: 10.1080/21541248.2016.1218407. Epub 2016 Aug 22.
7
Structural Basis for the Specific Recognition of RhoA by the Dual GTPase-activating Protein ARAP3.双GTP酶激活蛋白ARAP3对RhoA特异性识别的结构基础
J Biol Chem. 2016 Aug 5;291(32):16709-19. doi: 10.1074/jbc.M116.736140. Epub 2016 Jun 15.
8
Regulating Rho GTPases and their regulators.调节 Rho GTPases 及其调节因子。
Nat Rev Mol Cell Biol. 2016 Aug;17(8):496-510. doi: 10.1038/nrm.2016.67. Epub 2016 Jun 15.
9
Approaches of targeting Rho GTPases in cancer drug discovery.癌症药物研发中靶向Rho GTP酶的方法。
Expert Opin Drug Discov. 2015;10(9):991-1010. doi: 10.1517/17460441.2015.1058775. Epub 2015 Jun 18.
10
Rho GEFs and GAPs: emerging integrators of extracellular matrix signaling.Rho鸟嘌呤核苷酸交换因子和GTP酶激活蛋白:细胞外基质信号传导的新兴整合者
Small GTPases. 2015;6(1):16-9. doi: 10.4161/21541248.2014.989792.